175 related articles for article (PubMed ID: 10624128)
21. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
22. Disappearance of Ph1 chromosome with intensive chemotherapy and detection of minimal residual disease by polymerase chain reaction in a patient with blast crisis of chronic myelogenous leukemia.
Honda H; Miyagawa K; Endo M; Takaku F; Yazaki Y; Hirai H
Int J Hematol; 1993 Jun; 57(3):221-7. PubMed ID: 8364186
[TBL] [Abstract][Full Text] [Related]
23. Adoptive cell-mediated immunotherapy with interleukin-2 (IL-2) for relapsing lymphoblastic crisis following mismatched unrelated bone marrow transplantation in a chronic myelogenous leukemia patient.
Varadi G; Ackerstein A; Ben-Neriah S; Nagler A
Bone Marrow Transplant; 1998 Jan; 21(1):93-6. PubMed ID: 9486502
[TBL] [Abstract][Full Text] [Related]
24. Biphenotypic extramedullary blast crisis as a presenting manifestation of Philadelphia chromosome-positive CML in a child.
Ganessan K; Goel R; Kumar K; Bakhshi S
Pediatr Hematol Oncol; 2007; 24(3):195-8. PubMed ID: 17454789
[TBL] [Abstract][Full Text] [Related]
25. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
26. [Prominent lymphadenopathy and double Ph1 chromosomes as initial and recurrent manifestations of chronic myelogenous leukemia in blast crisis: report of a case and review of the literature].
Sakai C; Minamihisamatsu M; Takagi T; Oguro M; Maruyama K; Tanaka K; Kamada N
Rinsho Ketsueki; 1990 Sep; 31(9):1506-11. PubMed ID: 2246824
[TBL] [Abstract][Full Text] [Related]
27. Lymphoid preponderance and the absence of basophilia and splenomegaly are frequent in m-bcr-positive chronic myelogenous leukemia.
Hur M; Song EY; Kang SH; Shin DH; Kim JY; Park SS; Cho HI
Ann Hematol; 2002 Apr; 81(4):219-23. PubMed ID: 11976825
[TBL] [Abstract][Full Text] [Related]
28. [Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].
Qin YZ; Li JL; Zhu HH; Ruan GR; Li LD; Zhang Y; Xu LP; Liu DH; Liu YR; Huang XJ; Chen SS; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):511-4. PubMed ID: 17172121
[TBL] [Abstract][Full Text] [Related]
29. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
[TBL] [Abstract][Full Text] [Related]
30. [Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone].
Kuyama J; Take H
Rinsho Ketsueki; 1995 Dec; 36(12):1353-8. PubMed ID: 8587171
[TBL] [Abstract][Full Text] [Related]
31. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.
Saito Y; Uzuka Y; Sakai N; Suzuki S; Toyota T
Bone Marrow Transplant; 2000 Jun; 25(11):1209-11. PubMed ID: 10849535
[TBL] [Abstract][Full Text] [Related]
32. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
Schmetzer HM; Gerhartz HH
Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
[TBL] [Abstract][Full Text] [Related]
33. [The monitoring of BCR-ABL mRNA by reverse transcription PCR in patients undergoing allogeneic bone marrow transplantation for acute lymphoblastic leukemia with a positive Philadelphia chromosome].
Román J; Castillejo JA; Jiménez A; Maldonado J; Torres A
Med Clin (Barc); 1999 Dec; 113(20):779-82. PubMed ID: 10680143
[TBL] [Abstract][Full Text] [Related]
34. [Detection of bcr/abl gene expression on bone marrow cell colonies in chronic myelogenous leukemia by reverse transcriptase-polymerase chain reaction].
Luo Z; Chen H; Luo S; Tang L; Wang J
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):418-20. PubMed ID: 12080671
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
Wu B; Zhou S; Song L; Liu X
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
[TBL] [Abstract][Full Text] [Related]
36. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
Lahaye T; Riehm B; Berger U; Paschka P; Müller MC; Kreil S; Merx K; Schwindel U; Schoch C; Hehlmann R; Hochhaus A
Cancer; 2005 Apr; 103(8):1659-69. PubMed ID: 15747376
[TBL] [Abstract][Full Text] [Related]
37. Pathological fracture as a manifestation of extramedullary blastic crisis in chronic myelogenous leukemia: report of one case.
Yu HH; Lu MY; Lin DT; Lin KH; Tang JL; Jou ST
Acta Paediatr Taiwan; 2006; 47(3):150-4. PubMed ID: 17078470
[TBL] [Abstract][Full Text] [Related]
38. [Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR].
Qin YZ; Ruan GR; Liu YR; Li JL; Fu JY; Wang H; Chang Y; Jiang B; Jiang Q; Jiang H; Qiu JY; Chen SS; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):1-5. PubMed ID: 15946498
[TBL] [Abstract][Full Text] [Related]
39. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
[TBL] [Abstract][Full Text] [Related]
40. Growth kinetics and blast-colony forming cell binding capacity of stromal cells in various haematological malignancies.
el-Khatib Y; Gidáli J; Fehér I; Mód A; Poros A; Hollán S
Haematologia (Budap); 1991; 24(2):77-82. PubMed ID: 1816058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]